These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 26577998

  • 21. Comparison of cernitin pollen extract vs tadalafil therapy for refractory chronic prostatitis/chronic pelvic pain syndrome: A randomized, prospective study.
    Matsukawa Y, Naito Y, Funahashi Y, Ishida S, Fujita T, Tochigi K, Kato M, Gotoh M.
    Neurourol Urodyn; 2020 Sep; 39(7):1994-2002. PubMed ID: 32648985
    [Abstract] [Full Text] [Related]

  • 22. Issues in designing a randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome: Comment on Wang et al. Randomized controlled trial of levofloxacin, terazosin, and combination therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome. Int Urol Nephrol. 2016;48:13-18.
    Papeš D, Pasini M, Jerončić A.
    Int Urol Nephrol; 2017 Mar; 49(3):457-458. PubMed ID: 27378099
    [No Abstract] [Full Text] [Related]

  • 23. Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients.
    Cai T, Tiscione D, Gallelli L, Verze P, Palmieri A, Mirone V, Bartoletti R, Malossini G.
    Arch Ital Urol Androl; 2016 Oct 05; 88(3):177-182. PubMed ID: 27711089
    [Abstract] [Full Text] [Related]

  • 24. Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial.
    Nickel JC, Johnston B, Downey J, Barkin J, Pommerville P, Gregoire M, Ramsey E.
    Urology; 2000 Sep 01; 56(3):413-7. PubMed ID: 10962305
    [Abstract] [Full Text] [Related]

  • 25. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
    Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC.
    BJU Int; 2012 Oct 01; 110(7):1014-22. PubMed ID: 22471591
    [Abstract] [Full Text] [Related]

  • 26. Effects of Electroacupuncture with Different Waveforms on Chronic Prostatitis/Chronic Pelvic Pain Syndromes: A Randomized Controlled Trial.
    Li Z, Liu J, Liu P, Zhang Y, Han W.
    Contrast Media Mol Imaging; 2022 Oct 01; 2022():6866000. PubMed ID: 35935300
    [Abstract] [Full Text] [Related]

  • 27. Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study.
    Magri V, Perletti G, Cai T, Stamatiou K, Trinchieri A, Montanari E.
    Chemotherapy; 2019 Oct 01; 64(1):8-16. PubMed ID: 31112957
    [Abstract] [Full Text] [Related]

  • 28. [Preliminary experience in treatment of chronic prostatitis/chronic pelvic pain syndrome with Longjintonglin capsule].
    Shang XJ, Huang YF, Shao Y, Xue XT, Guan FG, Li G, Wang J.
    Zhonghua Nan Ke Xue; 2006 Apr 01; 12(4):371-3. PubMed ID: 16683576
    [Abstract] [Full Text] [Related]

  • 29. Erectile Dysfunction in Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Outcomes from a Multi-Center Study and Risk Factor Analysis in a Single Center.
    Zhang Y, Zheng T, Tu X, Chen X, Wang Z, Chen S, Yang Q, Wan Z, Han D, Xiao H, Sun X, Deng C.
    PLoS One; 2016 Apr 01; 11(4):e0153054. PubMed ID: 27120096
    [Abstract] [Full Text] [Related]

  • 30. The role of nutraceutical medications in men with non bacterial chronic prostatitis and chronic pelvic pain syndrome: A prospective non blinded study utilizing flower pollen extracts versus bioflavonoids.
    Maurizi A, De Luca F, Zanghi A, Manzi E, Leonardo C, Guidotti M, Antonaccio FP, Olivieri V, De Dominicis C.
    Arch Ital Urol Androl; 2019 Jan 18; 90(4):260-264. PubMed ID: 30655636
    [Abstract] [Full Text] [Related]

  • 31. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC, Narayan P, McKay J, Doyle C.
    J Urol; 2004 Apr 18; 171(4):1594-7. PubMed ID: 15017228
    [Abstract] [Full Text] [Related]

  • 32. A prospective study on association of prostatic calcifications with sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).
    Zhao Z, Xuan X, Zhang J, He J, Zeng G.
    J Sex Med; 2014 Oct 18; 11(10):2528-36. PubMed ID: 24735240
    [Abstract] [Full Text] [Related]

  • 33. Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.
    Magri V, Marras E, Restelli A, Wagenlehner FM, Perletti G.
    Exp Ther Med; 2015 Mar 18; 9(3):658-666. PubMed ID: 25667610
    [Abstract] [Full Text] [Related]

  • 34. Transurethral intraprostatic injection of botulinum neurotoxin type A for the treatment of chronic prostatitis/chronic pelvic pain syndrome: results of a prospective pilot double-blind and randomized placebo-controlled study.
    Falahatkar S, Shahab E, Gholamjani Moghaddam K, Kazemnezhad E.
    BJU Int; 2015 Oct 18; 116(4):641-9. PubMed ID: 25307409
    [Abstract] [Full Text] [Related]

  • 35. Tamsulosin treatment of chronic non-bacterial prostatitis.
    Ye ZQ, Lan RZ, Yang WM, Yao LF, Yu X.
    J Int Med Res; 2008 Oct 18; 36(2):244-52. PubMed ID: 18380933
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of Palmitoylethanolamide, Epilobium and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III.
    Morgia G, Lo Giudice A, Carrino M, Voce S, Cocci A, Reale G, Minervini A, Cimino S, Russo GI, Zingone F.
    Arch Ital Urol Androl; 2024 Jun 27; 96(2):12582. PubMed ID: 38934521
    [Abstract] [Full Text] [Related]

  • 37. A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of Curcumina and Calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III.
    Morgia G, Russo GI, Urzì D, Privitera S, Castelli T, Favilla V, Cimino S.
    Arch Ital Urol Androl; 2017 Jun 30; 89(2):110-113. PubMed ID: 28679180
    [Abstract] [Full Text] [Related]

  • 38. [Efficacy of compound Xuanju capsule in the treatment of chronic prostatitis with erectile dysfunction].
    Wang L, Liang P, Yang W, Zhou P, Huang XK, Liu JW, Chao WF, Yang H, Wang QT.
    Zhonghua Nan Ke Xue; 2012 Oct 30; 18(10):950-2. PubMed ID: 23297506
    [Abstract] [Full Text] [Related]

  • 39. Psychotherapy combined with drug therapy in patients with category III chronic prostatitis/chronic pelvic pain syndrome: A randomized controlled trial.
    Wang J, Liang K, Sun H, Li L, Wang H, Cao J.
    Int J Urol; 2018 Aug 30; 25(8):710-715. PubMed ID: 29862568
    [Abstract] [Full Text] [Related]

  • 40. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
    Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI.
    BJU Int; 2004 May 30; 93(7):991-5. PubMed ID: 15142149
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.